MGRX vs PLD · rev $456.0K vs P/E 27, rev $2.30B
Mangoceuticals, Inc. Common Stock (MGRX) versus Prologis Inc (PLD) — a side-by-side from cached financials, not a winner call.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Prologis Inc (PLD) is a reit - industrial company listed on US.
Latest reported MGRX revenue for 2025-12-31 was $456.0K. Net income was -$20.6M. Revenue was down 26.0% from 2024-12-31 to 2025-12-31. MGRX currently screens at market cap $16.3M.
Latest reported PLD revenue for 2026-03-31 was $2.30B. Net income was $982.0M. Revenue was up 2.0% from 2025-12-31 to 2026-03-31. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
MGRX currently screens at market cap $16.3M. PLD currently screens at market cap $100.23B and trailing P/E 26.9.
Not investment advice. Open the MGRX and PLD stock pages for the full models.
Not investment advice.